ICCM
IceCure MedicalยทNASDAQ
--
--(--)
--
--(--)
ICCM Profile
Icecure Medical Ltd.
A medical device company that developing advance treatment for cancerous tumors
Healthcare Equipment and Supplies
--
08/26/2021
NASDAQ Stock Exchange
64
12-31
Common stock
7 HaEshel St., PO Box 3163, Caesarea, 3079504 Israel
Focus on the research, development and marketing of cryoablation systems and technologies for the treatment of tumors with liquid nitrogen or LN 2.
IceCure Medical Ltd., was incorporated in Israel in 2006. The Company is a commercial-stage medical device company focused on the research, development and marketing of cryoablation systems and technologies for the treatment of tumors with liquid nitrogen or LN 2. Their proprietary cryoablation technology is a minimally invasive alternative to surgical intervention for tumors, including those found in breast, lung, kidney, bone and other indications. Their industry-leading commercial cryoablation product is the ProSense system.
